Cardiff Oncology Inc (CRDF)
Featured in
Bullish Trend Stocks
Cardiff Oncology Inc (CRDF) is a NASDAQ-listed company in the healthcare sector, classified in biotechnology. The security described here is Cardiff Oncology Inc common stock, meaning the listed common equity of the company on NASDAQ. The company is associated with oncology-focused biotechnology work and clinical-stage development activities, with an emphasis on researching potential cancer treatments. This overview reflects the trading instrument rather than a detailed operating profile, and it should be read as a description of the listed share class tied to Cardiff Oncology Inc on the NASDAQ exchange.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CRDF
|
$1.27
|
-4.6% Downside
|
Fair
|
$5.81
|
337.2% Upside
|
Bargain
|
Fair
|
0.0%
|
October 29, 2026
|
3.9x
|
203.7x
|
103.5 M
|
69.405 M
|
0.4%
|
96.9%
|
-14.0
|
102.1%
|
